3/31/2024 | 29415000 | Pharmaceutical Raw Material (Active Pharmaceutical Ingredients) Erythromycin Ethyl Succinate USP | XXXXXXXXXX | 150 | KGS | 14116.13 | PAKISTAN | JNPT NHAVA SHEVA SEA |
3/31/2024 | 29415000 | Pharmaceutical Raw Material (Active Pharmaceutical Ingredients) Erythromycin Ethyl Succinate USP | XXXXXXXXXX | 150 | KGS | 14116.13 | PAKISTAN | JNPT NHAVA SHEVA SEA |
3/22/2024 | 29415000 | ERYTHROMYCIN ETHYL SUCCINATE USP | XXXXXXXXXX | 1.5 | KGS | 16.86 | PAKISTAN | SAHAR AIR |
3/22/2024 | 29415000 | ERYTHROMYCIN STEARATE USP | XXXXXXXXXX | 4.5 | KGS | 43.08 | PAKISTAN | SAHAR AIR |
3/1/2024 | 30042061 | HARMLESS MEDICINES-ERYTHROMYCIN ETHYL SUCCINATE ORAL SUSPENSION BP 125MG/5ML UNIT:100 ML | XXXXXXXXXX | 53240 | NOS | 47437.01 | PAKISTAN | JNPT NHAVA SHEVA SEA |
2/29/2024 | 30042061 | HARMLESS MEDICINES-ERYTHROMYCIN ETHYL SUCCINATE ORAL SUSPENSION BP 125MG/5ML UNIT:100 MLNOS | XXXXXXXXXX | 67844.44 | NOS | 60544.41 | PAKISTAN | JNPT |
2/29/2024 | 30042061 | HARMLESS MEDICINES-ERYTHROMYCIN ETHYL SUCCINATE ORAL SUSPENSION BP 125MG/5ML UNIT:100 MLNOS | XXXXXXXXXX | 49990.64 | NOS | 44611.67 | PAKISTAN | JNPT |
2/29/2024 | 30042061 | HARMLESS MEDICINES-ERYTHROMYCIN ETHYL SUCCINATE ORAL SUSPENSION BP 125MG/5ML UNIT:100 MLNOS | XXXXXXXXXX | 60702.92 | NOS | 54171.32 | PAKISTAN | JNPT |
2/8/2024 | 30042061 | ERYTHROKID DRY SYRUP (ERYTHROMYCIN STEARATE FOR ORAL SUSPENSION U.S.P. XXII 125MG./5ML.)AD23004 MFG DATE 01/2024 EXP12NOS | XXXXXXXXXX | 11044.32 | NOS | 2207.69 | PAKISTAN | PATLI ICD |
2/8/2024 | 30042061 | ERYTHROKID DRY SYRUP (ERYTHROMYCIN STEARATE FOR ORAL SUSPENSION U.S.P. XXII 125MG./5ML.)AD23004 MFG DATE 01/2024 EXP12NOS | XXXXXXXXXX | 14988.72 | NOS | 2996.15 | PAKISTAN | PATLI ICD |